Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factors-Reference-Cited by-同舟云学术

Chronic myeloid leukaemia and tyrosine kinase inhibitor therapy: assessment and management of cardiovascular risk factors

Author:

Ross David M.¹,Arthur Chris²,Burbury Kate³,Ko Brian S.⁴,Mills Anthony K.⁵,Shortt Jake⁶⁷,Kostner Karam⁸

Affiliation:

1. Department of Haematology; Royal Adelaide Hospital and Flinders Medical Centre; Adelaide South Australia Australia

2. Royal North Shore Hospital; Sydney New South Wales Australia

3. Department of Haematology; Peter MacCallum Cancer Centre; Melbourne Victoria Australia

4. MonashHeart, Monash Health; Melbourne Victoria Australia

5. Division of Cancer Services; Princess Alexandra Hospital; Melbourne Victoria Australia

6. Monash Haematology, Department of Haematology; Monash Health; Melbourne Victoria Australia

7. School of Clinical Sciences at Monash Health, Faculty of Medicine, Nursing and Health Sciences; Monash University; Melbourne Victoria Australia

8. Department of Cardiology; Mater Hospital and University of Queensland; Brisbane Queensland Australia

Funder

Novartis

Publisher

Wiley

Subject

Internal Medicine

Link

Reference38 articles.

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献